Candida Infection
18
3
3
12
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 18 trials
100.0%
+13.5% vs benchmark
6%
1 trials in Phase 3/4
25%
3 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (18)
One-stage Exchange in Candida Periprosthetic Infection a Suitable Way to go
Biofilm Formation and Antifungal Resistance in Candida Species
Kinetics of Serum β-D-glucan During Peritonitis With Candida in Resuscitation
An Open-label Study of APX001 for Treatment of Patients With Candidemia/Invasive Candidiasis Caused by Candida Auris
Pharmacokinetic Study in Healthy Lactating Women Exposed to Ibrexafungerp
Oropharyngeal Candidiasis (OPC) and S-ECC
Analysis of Candida-Associated Osteoarticular Infections: Multicenter Turkish Data
Clinical Study to Evaluate the Efficacy of an Anti-Fungal Supplement
Safety of Pregnant Subjects Exposed to Ibrexafungerp Including Infant Outcomes
Mucormycosis in COVID-19
Research of New Serological Markers for the Diagnosis and Monitoring of Candidaemia in Hospitalized Patients
Effect of Medium Chain Triglyceride Intake on Colonization of Preterm Infants With Candida
HIV Indicator Diseases in Hospital and Primary Care
Ampholipad Real-World Data in Taiwan
The Anti-microbial Effect of Titanium Dioxide Nano Particles in Complete Dentures Made for Edentulous Patients
Clinical and Laboratorial Evaluation of the Desinfection Solutions in Candida Species From Total Prostheses and Palate of Total Edentulous.
Antifungal Prophylaxis in Intensive Care Unit (ICU) Patients
The Use of Probiotics in Patients With Symptomatic Oral Lichen Planus